• Scientists develop new class of cancer drug with potential to treat acute myeloid leukaemia (AML)
  • Using AI on Cytosponge samples to help detect Barrett's oesophagus cuts pathologists' workload and speeds up diagnosis
  • Early research findings could, in future, help screen women with BRCA mutations to more accurately assess their risk of breast cancer
  • Cambridge leads pioneering study to assess effectiveness of screening for kidney cancer
  • ‘Virtual biopsies’ could replace tissue biopsies thanks to technique developed by Cambridge scientists
  • Dr Raj Jena explains game-changing use of AI and machine learning to speed up radiotherapy preparations for cancer patients
  • Blood test already available for GPs is better at predicting ovarian cancer than previously thought
  • Government announces funding for a new Cambridge Cancer Research Hospital
  • "To me, this trial saved my life." Game-changing Cytosponge trial results are published in The Lancet
Our research programmes
Training cancer leaders
Putting patients first
CRUK Open Lab Initiative